To quote PracticalForecasting.com, “Forecasts
are a critical part of business planning, management, and strategy -- but
they're always wrong.” I think it depends (where have I heard those words
before) on your assumptions and desired or expected level of accuracy. I was deeply saddened this week when Southern
California Edison (SCE) announced that they would be permanently closing their
San Onofre Units. For those who don’t
know about it, here is a link to some information about the shutdown and
problem.
I had interviewed for an
Engineering Fix It Now (EFIN) Supervisor position at San Onofre about a week
before they initially shutdown because of the leaks in their almost new steam
generators that were manufactured by Mitsubishi. Although there will be some jobs remaining at
their site for decommissioning, I was kind of surprised at the number of
employees that they had there when I interviewed, about 2700. I guess I’ve gotten used to our small Vermont
Yankee staff of 600. Of course, when
they were operating at full uprated power, they were producing approximately 2150
Megawatts compared to 620 for Vermont Yankee.
Now, that carbon-free capacity is gone forever because of unnecessary
regulatory uncertainty. How many
windmills or solar panels does it take to replace 2150 Megawatts of carbon free
power or even the 70% of one unit’s capacity, which they planned to produce
without much regulatory interference and is still greater than the output of
our little VY plant? Either we’ll find
out or it will be replaced by more natural gas, which still emits carbon, or
coal plants, which kill more people per megawatt hour than any other power
source available. I’m guessing the later, since wind and solar require “farms”
to produce any appreciable capacity. Unfortunately,
the NRC decided they needed to rethink their own previous decision to allow
them to operate and it would take them more than a year to decide. I’m not blaming SCE for their decision. They face that certain uncertainty (our
regulatory inadequacy) that requires them to make the difficult decision to abandon
a product.
This week’s prompts included “what is the most important
thing you learned during the simulation?”
I think it’s that you have to balance how much effort you put into data
gathering, the situation analysis and the marketing plan. Outside situations, which may or may not
already be happening, can change your plans for you. I originally didn’t really consider the
allergy medication to be a viable product because I thought the market to be
too small. I didn’t realize that it would be the first non-drowsy allergy
relief medication on the market. Even
though the first to market doesn’t always lead the market, I saw this as an
opportunity to capitalize on our already good brand name to expand our mission
into the allergy relief market. It is
still an expensive product to produce and I don’t really know why, but it is
currently profitable enough to continue and shows promise since most customers
feel we are priced too low. Our team is
focused on market leadership rather than profitability or sales revenue. Those will follow once we have established
market leadership, but we are more concerned about providing the most relief
for our customers.
Although we didn’t specify it in our marketing plan, we did
consider the competitive advantage versus market attractiveness matrix. We gained competitive advantage with the
combination of Allround and Allround+ in the cold market, which also extended
into the cough and allergy markets. The
cold relief market continued to expand and we saw the opportunity to reach
children and others concerned with the alcohol and cough suppressants present
in our original formula, which we did not want to abandon because of brand
loyalty and market leadership. We knew
that the new formula would cannibalize some of the existing product, but felt
it would increase our overall market share in the cold relief market. As the allergy market consistently increased,
we recognized the market attractiveness potential for a non-drowsy formula,
even though it was not specifically stated (but forecast) in our original
marketing plan. The market
attractiveness of both the cold and allergy relief markets increased as those
were the two markets that were showing consistent growth above population
growth.
|
No comments:
Post a Comment